Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Label-free proteomic analysis of the hydrophobic membrane protein complement in articular chondrocytes: a technique for identification of membrane biomarkers

Matta C., Zhang X., Liddell S., Smith JR., Mobasheri A.

Animal Study, published in Biomarkers (2015) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Biomarkers (2015)
Reported sample size
—
Source database
Europe PMC
PMID
26864288
PMCID
PMC4819840
DOI
10.3109/1354750x.2015.1130191
Citations
9

Abstract (original English)

Context There is insufficient knowledge about the chondrocyte membranome and its molecular composition. Objective To develop a Triton X-114 based separation technique using nanoLC-MS/MS combined with shotgun proteomics to identify chondrocyte membrane proteins. Materials and methods Articular chondrocytes from equine metacarpophalangeal joints were separated into hydrophobic and hydrophilic fractions; trypsin-digested proteins were analysed by nanoLC-MS/MS. Results A total of 315 proteins were identified. The phase extraction method yielded a high proportion of membrane proteins (56%) including CD276, S100-A6 and three VDAC isoforms. Discussion Defining the chondrocyte membranome is likely to reveal new biomarker targets for conventional and biological drug discovery.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cartilage, ArticularMetacarpophalangeal JointCells, CulturedChondrocytesAnimalsHorsesPolyethylene GlycolsOctoxynolS100 ProteinsMembrane Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.